Novel oral anti-influenza prodrug candidate AV5075S | Zendy

Alexandre V. Ivachtchenko | Zendy; Yan A. Ivanenkov | Zendy; Oleg D. Mitkin | Zendy; Pavel Yamanushkin | Zendy; V. Bichko | Zendy; Natalia A. Shevkun | Zendy; O. V. Mokrushina | Zendy; O. O. Nevolina | Zendy; Ruben N. Karapetian | Zendy; Irina A. Leneva | Zendy; I. Т. Fedyakina | Zendy; Mark S. Veselov | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Novel oral anti-influenza prodrug candidate AV5075S

Author(s) -

Alexandre V. Ivachtchenko,

Yan A. Ivanenkov,

Oleg D. Mitkin,

Pavel Yamanushkin,

V. Bichko,

Natalia A. Shevkun,

O. V. Mokrushina,

O. O. Nevolina,

Ruben N. Karapetian,

Irina A. Leneva,

I. Т. Fedyakina,

Mark S. Veselov

Publication year - 2014

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkt507

Subject(s) - prodrug , drug candidate , neuraminidase inhibitor , pharmacokinetics , neuraminidase , pharmacology , in vivo , oseltamivir , virus , potency , influenza a virus , drug , docking (animal) , chemistry , in vitro , biology , virology , biochemistry , medicine , covid-19 , infectious disease (medical specialty) , disease , microbiology and biotechnology , nursing , pathology

Development of a novel drug candidate with improved activity against influenza virus neuraminidase (NA) compared with currently available therapeutics.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research